NEW YORK (GenomeWeb News) – Stem cell technologies company Cellular Dynamics International today announced it has filed with the US Securities and Exchange Commission to go public.

The Madison, Wis.-based firm filed its Form S-1 with SEC on Monday, saying it plans on an initial public offering to raise a maximum aggregate amount of $57.3 million. The price range for its shares and the number of shares to be offered have not been determined.

JP Morgan Securities is the sole book-running manager on the offering, while Cowen and Co. and Leerink Swann are co-managers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.